INFLIXIMAB-DYYB

INFLIXIMAB-DYYB was reported 3446 times

INFLIXIMAB-DYYB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HARVEY-BRADSHAW INDEX INCREASED 274 0.9195
1 EAR INFECTION BACTERIAL 59 0.2193
2 DRUG LEVEL BELOW THERAPEUTIC 1205 0.2182
3 FAECAL CALPROTECTIN INCREASED 636 0.2006
4 ANAL FISSURE 1067 0.1987
5 SINUSITIS BACTERIAL 199 0.1888
6 ANAL FISTULA INFECTION 25 0.1678
7 DRUG LEVEL ABOVE THERAPEUTIC 705 0.1538
8 BRONCHITIS BACTERIAL 96 0.1268
9 DRUG LEVEL DECREASED 1272 0.1249
10 WHITE COAT HYPERTENSION 66 0.1218
11 TREATMENT DELAYED 191 0.1103
12 DRUG SPECIFIC ANTIBODY PRESENT 683 0.1049
13 ANAL FISSURE HAEMORRHAGE 19 0.1033
14 APHTHOUS ULCER 766 0.0987
15 ERYTHEMA NODOSUM 339 0.0965
16 INTENTIONAL PRODUCT USE ISSUE 8411 0.0959
17 DRAIN PLACEMENT 24 0.0938
18 PHARYNGITIS BACTERIAL 24 0.0930
19 ILEOCAECAL RESECTION 31 0.0901
20 FISTULA DISCHARGE 112 0.0887
21 PILONIDAL DISEASE 21 0.0875
22 BODY TEMPERATURE FLUCTUATION 179 0.0859
23 EXPOSURE TO SARS-COV-2 146 0.0858
24 STEROID DEPENDENCE 74 0.0843
25 STOMA CLOSURE 26 0.0836
26 FISTULA 922 0.0819
27 BLOOD PRESSURE DIASTOLIC INCREASED 377 0.0816
28 BLOOD PRESSURE FLUCTUATION 1953 0.0813
29 VAGINAL FLATULENCE 24 0.0792
30 POOR VENOUS ACCESS 819 0.0791
31 PSEUDOPOLYP 28 0.0778
32 SUSPECTED OFF LABEL USE 344 0.0761
33 BLOOD PRESSURE DIASTOLIC DECREASED 558 0.0755
34 ANAL FISTULA 401 0.0751
35 VEIN RUPTURE 115 0.0687
36 FAECAL CALPROTECTIN ABNORMAL 28 0.0675
37 VAGINAL FISTULA 24 0.0667
38 VEIN COLLAPSE 51 0.0664
39 CATARRH 60 0.0664
40 INFECTED FISTULA 34 0.0634
41 NEUROGENIC SHOCK 32 0.0590
42 THERAPEUTIC RESPONSE SHORTENED 1929 0.0581
43 OSTOMY BAG PLACEMENT 26 0.0579
44 UVEITIS 772 0.0569
45 RECTAL ABSCESS 94 0.0560
46 ANAL ABSCESS 302 0.0560
47 INFUSION SITE EXTRAVASATION 337 0.0541
48 PYODERMA GANGRENOSUM 192 0.0533
49 PRODUCT SUBSTITUTION 21 0.0520
50 URINARY TRACT INFECTION BACTERIAL 131 0.0518
51 ROOT CANAL INFECTION 25 0.0507
52 DRAINAGE 25 0.0507
53 BODY TEMPERATURE DECREASED 499 0.0506
54 MUCOUS STOOLS 247 0.0498
55 DRUG LEVEL ABNORMAL 26 0.0490
56 DEFAECATION URGENCY 337 0.0480
57 DRUG SPECIFIC ANTIBODY 65 0.0474
58 ABSCESS 735 0.0460
59 BLOOD PRESSURE SYSTOLIC INCREASED 877 0.0449
60 HEART RATE DECREASED 1560 0.0444
61 RECTAL TENESMUS 55 0.0441
62 PHARYNGEAL PARAESTHESIA 70 0.0441
63 LOSS OF THERAPEUTIC RESPONSE 140 0.0439
64 ANASTOMOTIC ULCER 20 0.0435
65 STOMA CREATION 30 0.0432
66 EYE INFECTION BACTERIAL 24 0.0430
67 WISDOM TEETH REMOVAL 56 0.0425
68 INFUSION SITE DISCOMFORT 41 0.0395
69 BURNS SECOND DEGREE 69 0.0393
70 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 7053 0.0391
71 TERMINAL ILEITIS 23 0.0375
72 INTESTINAL ANASTOMOSIS 24 0.0373
73 SERUM FERRITIN DECREASED 64 0.0370
74 PROCTITIS 102 0.0364
75 ANAL INFLAMMATION 23 0.0360
76 ANAL STENOSIS 19 0.0356
77 CONDITION AGGRAVATED 10836 0.0356
78 INTENTIONAL DOSE OMISSION 1007 0.0353
79 INFUSION RELATED HYPERSENSITIVITY REACTION 20 0.0333
80 ABSCESS DRAINAGE 28 0.0323
81 WEIGHT FLUCTUATION 332 0.0317
82 SUSPECTED COVID-19 104 0.0315
83 INFUSION SITE OEDEMA 26 0.0311
84 ENTHESOPATHY 48 0.0307
85 ANTIBODY TEST ABNORMAL 22 0.0306
86 FEMALE GENITAL TRACT FISTULA 52 0.0304
87 INGROWN HAIR 21 0.0303
88 HEART RATE IRREGULAR 672 0.0297
89 ENTEROCUTANEOUS FISTULA 26 0.0295
90 ILEAL STENOSIS 52 0.0292
91 AXIAL SPONDYLOARTHRITIS 25 0.0284
92 DISCHARGE 39 0.0281
93 OXYGEN SATURATION ABNORMAL 79 0.0278
94 ANORECTAL DISORDER 55 0.0276
95 NASAL DISCHARGE DISCOLOURATION 37 0.0268
96 PROCTALGIA 172 0.0267
97 ILEAL ULCER 27 0.0267
98 INTESTINAL RESECTION 141 0.0262
99 INFECTED CYST 31 0.0258
100 STRESS AT WORK 29 0.0257
101 LARGE INTESTINAL STENOSIS 51 0.0255
102 ILEOSTOMY 65 0.0254
103 SMALL INTESTINAL STENOSIS 27 0.0254
104 MAMMOPLASTY 20 0.0250
105 INFECTED BITE 21 0.0247
106 ANTIBIOTIC THERAPY 23 0.0236
107 HAEMATOCHEZIA 1287 0.0233
108 INFUSION SITE BRUISING 50 0.0231
109 AXILLARY MASS 24 0.0231
110 DRUG PRESCRIBING ERROR 441 0.0229
111 TOOTH INFECTION 300 0.0227
112 FREQUENT BOWEL MOVEMENTS 610 0.0226
113 ALCOHOL POISONING 60 0.0224
114 BACTERIAL VAGINOSIS 35 0.0224
115 SINUS PAIN 52 0.0223
116 INTESTINAL ULCER 35 0.0220
117 SACROILIITIS 41 0.0217
118 INTESTINAL STENOSIS 91 0.0216
119 STREPTOCOCCAL INFECTION 119 0.0214
120 PHARYNGITIS STREPTOCOCCAL 227 0.0210
121 IRON DEFICIENCY 92 0.0204
122 ABSCESS INTESTINAL 44 0.0204
123 BLOODY DISCHARGE 23 0.0201
124 TYMPANIC MEMBRANE PERFORATION 34 0.0201
125 COLITIS ULCERATIVE 899 0.0201
126 DERMATITIS PSORIASIFORM 41 0.0200
127 DYSCHEZIA 61 0.0200
128 INTESTINAL FISTULA 28 0.0199
129 HYPOPNOEA 68 0.0196
130 INTESTINAL OPERATION 31 0.0196
131 FAECES SOFT 139 0.0191
132 SMALL INTESTINAL RESECTION 22 0.0189
133 MEAN CELL VOLUME DECREASED 29 0.0188
134 GASTROINTESTINAL WALL THICKENING 28 0.0187
135 CLOSTRIDIUM DIFFICILE INFECTION 404 0.0185
136 MOUTH ULCERATION 379 0.0180
137 OFF LABEL USE 15556 0.0177
138 SYMPTOM RECURRENCE 105 0.0175
139 GASTROINTESTINAL BACTERIAL INFECTION 20 0.0175
140 WOUND SECRETION 68 0.0173
141 POSTOPERATIVE WOUND COMPLICATION 22 0.0173
142 OTORRHOEA 30 0.0172
143 STENOSIS 32 0.0170
144 COCCYDYNIA 25 0.0170
145 COLECTOMY 95 0.0168
146 ABSCESS ORAL 23 0.0168
147 DENTAL OPERATION 41 0.0166
148 LARGE INTESTINAL ULCER 45 0.0166
149 ANIMAL BITE 44 0.0165
150 ABSCESS LIMB 70 0.0164
151 INFUSION SITE SWELLING 103 0.0164
152 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 27 0.0162
153 TONSILLITIS 84 0.0161
154 ANORECTAL DISCOMFORT 85 0.0160
155 ACROCHORDON 21 0.0158
156 MEAN CELL HAEMOGLOBIN DECREASED 29 0.0158
157 BLOOD PRESSURE INCREASED 2396 0.0157
158 ARTHROPOD STING 26 0.0156
159 UMBILICAL HERNIA 73 0.0156
160 OTITIS EXTERNA 19 0.0155
161 APPENDIX DISORDER 22 0.0155
162 VAGINAL INFECTION 73 0.0155
163 RENAL COLIC 35 0.0155
164 TONSILLAR HYPERTROPHY 26 0.0155
165 TOOTH ABSCESS 157 0.0154
166 RED CELL DISTRIBUTION WIDTH INCREASED 64 0.0154
167 ACCIDENT AT WORK 34 0.0154
168 DIARRHOEA HAEMORRHAGIC 143 0.0153
169 COLOSTOMY 30 0.0153
170 PUSTULE 36 0.0152
171 INDURATION 27 0.0151
172 BOWEL MOVEMENT IRREGULARITY 116 0.0151
173 INTESTINAL DILATATION 20 0.0150
174 ENDODONTIC PROCEDURE 38 0.0150
175 PRODUCT PRESCRIBING ISSUE 320 0.0147
176 GASTROINTESTINAL STOMA COMPLICATION 23 0.0146
177 INFUSION SITE PAIN 188 0.0146
178 RHINITIS 117 0.0145
179 POSTOPERATIVE WOUND INFECTION 98 0.0145
180 FAECES HARD 56 0.0144
181 WEIGHT INCREASED 3202 0.0143
182 NASAL CONGESTION 830 0.0141
183 GASTROINTESTINAL OBSTRUCTION 33 0.0137
184 LIMB MASS 30 0.0136
185 GASTROINTESTINAL INFLAMMATION 107 0.0136
186 SKIN PLAQUE 115 0.0136
187 INFUSION SITE PRURITUS 43 0.0136
188 SKIN INFECTION 152 0.0135
189 COVID-19 2373 0.0135
190 SPUTUM DISCOLOURED 128 0.0135
191 OROPHARYNGEAL PAIN 1249 0.0135
192 HORDEOLUM 58 0.0134
193 RESPIRATORY RATE INCREASED 117 0.0132
194 CHOLANGITIS SCLEROSING 27 0.0131
195 WOUND COMPLICATION 45 0.0131
196 C-REACTIVE PROTEIN INCREASED 477 0.0131
197 FOOD POISONING 70 0.0131
198 BODY TEMPERATURE ABNORMAL 24 0.0130
199 RECTAL HAEMORRHAGE 548 0.0127
200 PRODUCT DISTRIBUTION ISSUE 118 0.0127
201 IMPAIRED QUALITY OF LIFE 181 0.0126
202 INGUINAL HERNIA 76 0.0125
203 DEEP VEIN THROMBOSIS POSTOPERATIVE 25 0.0125
204 EAR INFECTION 332 0.0125
205 BODY TEMPERATURE INCREASED 253 0.0124
206 SECRETION DISCHARGE 154 0.0123
207 DENTAL IMPLANTATION 20 0.0122
208 DERMAL CYST 30 0.0122
209 OPHTHALMIC HERPES ZOSTER 22 0.0122
210 POST PROCEDURAL INFECTION 99 0.0122
211 ARTHRALGIA 5043 0.0121
212 ANAL INCONTINENCE 109 0.0121
213 ANKYLOSING SPONDYLITIS 159 0.0121
214 HAEMORRHOIDS 235 0.0120
215 INTESTINAL OBSTRUCTION 452 0.0120
216 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 849 0.0119
217 PHARYNGITIS 147 0.0118
218 ABNORMAL FAECES 97 0.0118
219 ANAL HAEMORRHAGE 33 0.0118
220 EYE INFECTION 133 0.0118
221 ABDOMINAL ABSCESS 52 0.0118
222 BLOOD IRON DECREASED 139 0.0117
223 DRUG LEVEL INCREASED 192 0.0116
224 RESPIRATORY TRACT INFECTION VIRAL 27 0.0116
225 GINGIVAL PAIN 92 0.0115
226 OBSTRUCTION 46 0.0115
227 RHINORRHOEA 742 0.0115
228 POLYARTHRITIS 60 0.0114
229 NEPHROLITHIASIS 522 0.0114
230 HIDRADENITIS 103 0.0113
231 FUNCTIONAL GASTROINTESTINAL DISORDER 39 0.0113
232 TENOSYNOVITIS 31 0.0112
233 IRITIS 34 0.0112
234 POLYP 73 0.0111
235 INCORRECT DOSAGE ADMINISTERED 54 0.0110
236 WEIGHT DECREASED 3081 0.0110
237 NASOPHARYNGITIS 2010 0.0109
238 SUBCUTANEOUS ABSCESS 52 0.0108
239 BRONCHIECTASIS 73 0.0108
240 THERAPEUTIC PRODUCT EFFECT DELAYED 49 0.0107
241 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 69 0.0106
242 WOUND INFECTION 116 0.0106
243 INGROWING NAIL 25 0.0106
244 SUBILEUS 22 0.0106
245 ABDOMINAL HERNIA 48 0.0105
246 TOOTH EXTRACTION 130 0.0104
247 CHRONIC SINUSITIS 39 0.0104
248 HEART RATE ABNORMAL 57 0.0102
249 PALLOR 276 0.0101
250 UNDERDOSE 739 0.0101
251 SARCOIDOSIS 48 0.0101
252 LUPUS-LIKE SYNDROME 90 0.0099
253 EAR SWELLING 21 0.0099
254 VULVOVAGINAL MYCOTIC INFECTION 39 0.0099
255 INFLAMMATION 509 0.0099
256 HAEMORRHOIDAL HAEMORRHAGE 48 0.0098
257 INFECTIOUS MONONUCLEOSIS 22 0.0098
258 LOCALISED INFECTION 236 0.0097
259 CYST 121 0.0097
260 INFLUENZA 1087 0.0097
261 SKIN LACERATION 105 0.0096
262 MELANOCYTIC NAEVUS 42 0.0096
263 EAR DISCOMFORT 98 0.0095
264 WOUND 264 0.0094
265 EYE OEDEMA 23 0.0094
266 ILLNESS 964 0.0093
267 INFLAMMATORY BOWEL DISEASE 91 0.0093
268 PRODUCTIVE COUGH 442 0.0092
269 ENTERITIS 59 0.0092
270 LIGAMENT SPRAIN 91 0.0092
271 PURULENT DISCHARGE 39 0.0091
272 MATERNAL EXPOSURE TIMING UNSPECIFIED 34 0.0090
273 PNEUMONIA BACTERIAL 83 0.0090
274 ABDOMINAL MASS 24 0.0090
275 PAROSMIA 67 0.0089
276 GASTROENTERITIS 129 0.0088
277 INFREQUENT BOWEL MOVEMENTS 22 0.0088
278 FEAR OF INJECTION 63 0.0088
279 LIGAMENT RUPTURE 39 0.0088
280 ORAL HERPES 172 0.0088
281 ORAL INFECTION 34 0.0087
282 SKIN LESION 237 0.0086
283 INFUSION RELATED REACTION 571 0.0086
284 PERIPHERAL VENOUS DISEASE 35 0.0086
285 WEIGHT BEARING DIFFICULTY 23 0.0085
286 PROSTATITIS 26 0.0085
287 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 410 0.0085
288 CONCUSSION 66 0.0085
289 OROPHARYNGEAL DISCOMFORT 76 0.0084
290 RADICULOPATHY 22 0.0083
291 HAND FRACTURE 59 0.0083
292 HYPERTONIC BLADDER 24 0.0083
293 PHLEBITIS 42 0.0082
294 FURUNCLE 65 0.0082
295 INSURANCE ISSUE 125 0.0082
296 SENSITIVITY TO WEATHER CHANGE 43 0.0082
297 HEART RATE INCREASED 809 0.0082
298 COLITIS 307 0.0081
299 LIMB INJURY 219 0.0081
300 INCORRECT DRUG ADMINISTRATION RATE 34 0.0080
301 FACET JOINT SYNDROME 26 0.0080
302 CARDIAC MURMUR 69 0.0080
303 LYMPHOCYTE COUNT INCREASED 26 0.0080
304 HERNIA 154 0.0080
305 SMALL INTESTINAL OBSTRUCTION 98 0.0080
306 KIDNEY INFECTION 156 0.0079
307 PARANASAL SINUS DISCOMFORT 30 0.0079
308 EAR PAIN 154 0.0079
309 LABYRINTHITIS 20 0.0079
310 FOLLICULITIS 82 0.0078
311 LARGE INTESTINE POLYP 54 0.0078
312 LIPOMA 20 0.0077
313 MONOCYTE COUNT INCREASED 28 0.0077
314 FLANK PAIN 72 0.0077
315 GASTROINTESTINAL SOUNDS ABNORMAL 38 0.0077
316 LOWER RESPIRATORY TRACT INFECTION 348 0.0076
317 EAR DISORDER 35 0.0076
318 VEIN DISORDER 38 0.0076
319 INFUSION SITE ERYTHEMA 64 0.0076
320 GASTROINTESTINAL INFECTION 68 0.0076
321 HIP SURGERY 41 0.0076
322 BACTERIAL INFECTION 140 0.0075
323 EATING DISORDER 159 0.0075
324 FOOD INTOLERANCE 27 0.0074
325 FEELING HOT 451 0.0073
326 C-REACTIVE PROTEIN ABNORMAL 47 0.0073
327 INFUSION SITE HAEMORRHAGE 24 0.0073
328 APPENDICECTOMY 26 0.0073
329 SPINAL STENOSIS 30 0.0073
330 PULMONARY PAIN 21 0.0072
331 SINUS CONGESTION 97 0.0072
332 APHONIA 100 0.0072
333 INCORRECT DOSE ADMINISTERED 1633 0.0071
334 SPONDYLITIS 26 0.0071
335 SYNOVIAL CYST 33 0.0071
336 ARTHRITIS 562 0.0071
337 TOOTH DISORDER 158 0.0071
338 SPINAL PAIN 83 0.0071
339 ABDOMINAL PAIN 1641 0.0070
340 SCAB 80 0.0070
341 BURSITIS 85 0.0070
342 FUNGAL SKIN INFECTION 28 0.0069
343 UPPER RESPIRATORY TRACT CONGESTION 20 0.0069
344 SINUSITIS 707 0.0069
345 FEELING COLD 190 0.0068
346 RECTAL DISCHARGE 25 0.0068
347 THERAPEUTIC RESPONSE CHANGED 43 0.0068
348 THYROID MASS 26 0.0068
349 MALAISE 2968 0.0068
350 CYSTITIS 215 0.0067
351 THERAPY INTERRUPTED 482 0.0067
352 JOINT INJURY 144 0.0067
353 TOOTHACHE 122 0.0067
354 SKIN PAPILLOMA 27 0.0067
355 COUGH 1884 0.0067
356 ABDOMINAL DISTENSION 700 0.0067
357 BLOOD ALBUMIN DECREASED 53 0.0067
358 WRIST FRACTURE 80 0.0067
359 ABDOMINAL ADHESIONS 21 0.0066
360 PRODUCT TEMPERATURE EXCURSION ISSUE 34 0.0066
361 ECZEMA 346 0.0066
362 UNEVALUABLE EVENT 500 0.0066
363 TRIGGER FINGER 27 0.0066
364 PLANTAR FASCIITIS 22 0.0066
365 FEEDING DISORDER 133 0.0066
366 TOOTH FRACTURE 72 0.0065
367 RED BLOOD CELL SEDIMENTATION RATE INCREASED 72 0.0065
368 GINGIVITIS 35 0.0065
369 AUTOIMMUNE HEPATITIS 45 0.0065
370 THROAT TIGHTNESS 175 0.0065
371 ARTHRITIS INFECTIVE 30 0.0065
372 ABDOMINAL PAIN LOWER 163 0.0064
373 CARPAL TUNNEL SYNDROME 90 0.0064
374 THROAT IRRITATION 288 0.0064
375 PUSTULAR PSORIASIS 22 0.0064
376 PRODUCT USE ISSUE 1198 0.0064
377 RESPIRATORY RATE DECREASED 20 0.0064
378 PHARYNGEAL SWELLING 62 0.0063
379 JOINT STIFFNESS 166 0.0063
380 CONJUNCTIVITIS 117 0.0063
381 ENDOMETRIOSIS 30 0.0063
382 ARTHROPOD BITE 46 0.0062
383 EYE INFLAMMATION 59 0.0062
384 HERPES ZOSTER 355 0.0062
385 VIRAL INFECTION 205 0.0062
386 FEELING OF BODY TEMPERATURE CHANGE 36 0.0061
387 CHEST DISCOMFORT 626 0.0061
388 OVARIAN CYST 61 0.0061
389 MUSCULOSKELETAL STIFFNESS 534 0.0061
390 DRUG EFFECT LESS THAN EXPECTED 90 0.0061
391 ULCER 96 0.0060
392 CELLULITIS 304 0.0060
393 OVERDOSE 1299 0.0060
394 BLOOD PRESSURE DECREASED 399 0.0060
395 KNEE OPERATION 59 0.0060
396 BLEPHARITIS 24 0.0060
397 JOINT RANGE OF MOTION DECREASED 80 0.0060
398 SEASONAL ALLERGY 84 0.0059
399 CHILLS 691 0.0059
400 MATERNAL EXPOSURE DURING PREGNANCY 524 0.0059
401 GASTROENTERITIS VIRAL 106 0.0059
402 OXYGEN SATURATION DECREASED 329 0.0058
403 INCREASED UPPER AIRWAY SECRETION 30 0.0058
404 ABDOMINAL TENDERNESS 29 0.0058
405 LIMB OPERATION 28 0.0058
406 PAPULE 41 0.0058
407 REFUSAL OF TREATMENT BY PATIENT 38 0.0058
408 GASTROINTESTINAL PAIN 64 0.0058
409 THERAPY NON-RESPONDER 260 0.0058
410 IMMUNOSUPPRESSION 51 0.0058
411 ORAL CANDIDIASIS 76 0.0058
412 BRONCHITIS 426 0.0057
413 GINGIVAL DISORDER 22 0.0057
414 THROMBOPHLEBITIS 20 0.0057
415 IMPAIRED WORK ABILITY 121 0.0057
416 PERIORBITAL SWELLING 32 0.0057
417 MUSCLE RUPTURE 22 0.0056
418 INFLUENZA LIKE ILLNESS 465 0.0056
419 NERVE COMPRESSION 52 0.0056
420 FLATULENCE 319 0.0056
421 MUSCULOSKELETAL CHEST PAIN 87 0.0056
422 GASTROINTESTINAL MOTILITY DISORDER 30 0.0056
423 SYNOVITIS 101 0.0056
424 POOR QUALITY SLEEP 120 0.0056
425 FRUSTRATION TOLERANCE DECREASED 45 0.0056
426 NEUTROPHIL COUNT INCREASED 57 0.0056
427 ACCIDENT 66 0.0055
428 HYPERTENSION 1166 0.0055
429 BLOOD PRESSURE SYSTOLIC DECREASED 25 0.0055
430 ATTENTION DEFICIT HYPERACTIVITY DISORDER 23 0.0055
431 APPENDICITIS 51 0.0055
432 ERYTHEMA 1119 0.0054
433 EXPOSURE VIA SKIN CONTACT 141 0.0054
434 MATERNAL EXPOSURE DURING BREAST FEEDING 22 0.0054
435 EAR PRURITUS 19 0.0054
436 INFECTION 784 0.0054
437 FOOT FRACTURE 102 0.0054
438 RENAL PAIN 57 0.0054
439 ROSACEA 25 0.0054
440 MIGRAINE 510 0.0053
441 SENSATION OF FOREIGN BODY 45 0.0053
442 SYSTEMIC LUPUS ERYTHEMATOSUS 189 0.0053
443 THERAPEUTIC PRODUCT EFFECT DECREASED 238 0.0053
444 IRON DEFICIENCY ANAEMIA 49 0.0053
445 FOOT OPERATION 26 0.0052
446 TONGUE DISORDER 38 0.0052
447 MENISCUS INJURY 32 0.0052
448 INCONTINENCE 55 0.0052
449 EYE DISCHARGE 54 0.0052
450 PYREXIA 1773 0.0051
451 PRODUCT PRESCRIBING ERROR 122 0.0051
452 PRODUCT ADMINISTRATION INTERRUPTED 40 0.0051
453 LYMPHADENOPATHY 180 0.0051
454 JOINT EFFUSION 35 0.0051
455 SKIN DISORDER 169 0.0051
456 ACNE 384 0.0051
457 PRODUCT SUPPLY ISSUE 36 0.0050
458 HERPES VIRUS INFECTION 29 0.0050
459 DIVERTICULUM INTESTINAL 22 0.0050
460 VITAMIN D DECREASED 43 0.0050
461 IMMUNE SYSTEM DISORDER 66 0.0050
462 THERAPY CHANGE 49 0.0050
463 HEAD DISCOMFORT 88 0.0050
464 BACK PAIN 1153 0.0050
465 GALLBLADDER OPERATION 20 0.0049
466 TENDERNESS 51 0.0049
467 SCIATICA 78 0.0049
468 SKIN ABRASION 23 0.0049
469 CATARACT 289 0.0048
470 RHEUMATOID FACTOR POSITIVE 28 0.0048
471 VAGINAL DISCHARGE 49 0.0048
472 PROSTATOMEGALY 19 0.0048
473 DISCOMFORT 295 0.0048
474 PLATELET COUNT INCREASED 63 0.0048
475 GESTATIONAL DIABETES 23 0.0048
476 HAEMOGLOBIN INCREASED 22 0.0048
477 SKIN WARM 28 0.0048
478 PARONYCHIA 21 0.0048
479 IMMUNODEFICIENCY 71 0.0048
480 PRODUCT AVAILABILITY ISSUE 108 0.0047
481 MUSCLE STRAIN 41 0.0047
482 FLUSHING 481 0.0047
483 NEUROLOGICAL SYMPTOM 27 0.0047
484 RASH MACULAR 164 0.0047
485 PRESYNCOPE 114 0.0047
486 MOUTH SWELLING 27 0.0047
487 BASAL CELL CARCINOMA 73 0.0047
488 SKIN MASS 31 0.0046
489 PERICARDITIS 78 0.0046
490 DIZZINESS POSTURAL 45 0.0046
491 GOUT 83 0.0046
492 RIB FRACTURE 95 0.0046
493 HYSTERECTOMY 40 0.0046
494 BREAST MASS 31 0.0046
495 GALLBLADDER DISORDER 82 0.0046
496 TREATMENT FAILURE 379 0.0046
497 HELICOBACTER INFECTION 47 0.0046
498 MICTURITION URGENCY 52 0.0045
499 ODYNOPHAGIA 27 0.0045
500 FATIGUE 3510 0.0045
501 BACK INJURY 49 0.0045
502 PYELONEPHRITIS 39 0.0045
503 DIVERTICULITIS 124 0.0045
504 FAECES DISCOLOURED 97 0.0045
505 INTERVERTEBRAL DISC PROTRUSION 97 0.0044
506 DERMATITIS ACNEIFORM 27 0.0044
507 MUSCULOSKELETAL DISCOMFORT 76 0.0044
508 SKIN CANCER 95 0.0044
509 OSTEOARTHRITIS 187 0.0044
510 NIGHT SWEATS 142 0.0044
511 FIBROMYALGIA 107 0.0044
512 CHOLECYSTECTOMY 50 0.0044
513 MOBILITY DECREASED 314 0.0044
514 ORAL DISORDER 32 0.0044
515 CLOSTRIDIUM DIFFICILE COLITIS 46 0.0043
516 BLADDER DISORDER 43 0.0043
517 ANKLE FRACTURE 67 0.0043
518 RASH ERYTHEMATOUS 206 0.0043
519 AUTOIMMUNE DISORDER 42 0.0043
520 DRUG DELIVERY SYSTEM MALFUNCTION 22 0.0043
521 DUODENAL ULCER PERFORATION 32 0.0043
522 ROAD TRAFFIC ACCIDENT 179 0.0043
523 TIBIA FRACTURE 20 0.0043
524 SARS-COV-2 TEST POSITIVE 56 0.0042
525 SNEEZING 95 0.0042
526 ECCHYMOSIS 29 0.0042
527 URINARY TRACT INFECTION 721 0.0042
528 APPETITE DISORDER 28 0.0042
529 GAIT INABILITY 141 0.0042
530 PRESCRIBED OVERDOSE 81 0.0042
531 PRODUCT DOSE OMISSION ISSUE 1227 0.0042
532 GASTROINTESTINAL DISORDER 373 0.0042
533 PARAESTHESIA ORAL 60 0.0042
534 NASAL DRYNESS 26 0.0041
535 FACIAL PAIN 37 0.0041
536 JOINT SWELLING 499 0.0041
537 ROTATOR CUFF SYNDROME 53 0.0041
538 MASS 57 0.0041
539 PERIPHERAL COLDNESS 56 0.0041
540 DISEASE RECURRENCE 194 0.0041
541 OCULAR HYPERAEMIA 193 0.0041
542 VARICOSE VEIN 21 0.0041
543 FUNGAL INFECTION 135 0.0040
544 HIP ARTHROPLASTY 62 0.0040
545 NECK PAIN 226 0.0040
546 RESPIRATORY TRACT CONGESTION 64 0.0040
547 PERIPHERAL SWELLING 620 0.0040
548 FAECALOMA 22 0.0040
549 INTESTINAL PERFORATION 45 0.0040
550 UTERINE LEIOMYOMA 29 0.0040
551 HEADACHE 2469 0.0039
552 RHEUMATOID ARTHRITIS 444 0.0039
553 NODULE 51 0.0039
554 ARTHROPATHY 217 0.0039
555 HOT FLUSH 294 0.0039
556 HYPERAESTHESIA 32 0.0039
557 PRURITUS 1482 0.0039
558 PAIN 2363 0.0038
559 RASH PRURITIC 208 0.0038
560 MOVEMENT DISORDER 123 0.0038
561 SWELLING OF EYELID 24 0.0038
562 ASTHENOPIA 21 0.0038
563 PAIN IN EXTREMITY 1125 0.0038
564 PROSTATIC DISORDER 21 0.0038
565 SENSITIVE SKIN 28 0.0038
566 INCORRECT PRODUCT ADMINISTRATION DURATION 82 0.0038
567 JOINT DISLOCATION 40 0.0038
568 HEAVY MENSTRUAL BLEEDING 34 0.0038
569 URTICARIA 630 0.0038
570 IMPAIRED HEALING 123 0.0037
571 MALIGNANT MELANOMA 50 0.0037
572 PELVIC FRACTURE 29 0.0037
573 KNEE ARTHROPLASTY 78 0.0037
574 WRONG PRODUCT ADMINISTERED 25 0.0037
575 ABDOMINAL DISCOMFORT 619 0.0037
576 TENDONITIS 57 0.0037
577 VERTIGO 224 0.0037
578 CONSTIPATION 799 0.0037
579 RESPIRATORY TRACT INFECTION 95 0.0036
580 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 26 0.0036
581 ABORTION SPONTANEOUS 145 0.0036
582 MENTAL DISORDER 157 0.0036
583 LOWER LIMB FRACTURE 69 0.0036
584 RETINAL DETACHMENT 33 0.0036
585 DRUG EFFECT INCOMPLETE 130 0.0036
586 COLD SWEAT 63 0.0036
587 WHITE BLOOD CELL COUNT INCREASED 137 0.0036
588 RASH PUSTULAR 26 0.0036
589 DECREASED IMMUNE RESPONSIVENESS 35 0.0036
590 UPPER LIMB FRACTURE 71 0.0036
591 IRRITABLE BOWEL SYNDROME 76 0.0035
592 SWELLING 331 0.0035
593 PAIN IN JAW 100 0.0035
594 ABDOMINAL PAIN UPPER 726 0.0035
595 THERMAL BURN 25 0.0035
596 SWOLLEN TONGUE 110 0.0035
597 PROCEDURAL PAIN 97 0.0035
598 MALNUTRITION 39 0.0035
599 TUBULOINTERSTITIAL NEPHRITIS 65 0.0035
600 PSORIASIS 452 0.0035
601 PSORIATIC ARTHROPATHY 140 0.0034
602 BRAIN FOG 54 0.0034
603 DRY THROAT 35 0.0034
604 POST PROCEDURAL COMPLICATION 66 0.0034
605 GROIN PAIN 30 0.0034
606 HYPERHIDROSIS 438 0.0034
607 CHOLANGITIS 21 0.0034
608 FOOT DEFORMITY 37 0.0033
609 SKIN REACTION 47 0.0033
610 BLOOD URINE PRESENT 63 0.0033
611 LIP DRY 30 0.0033
612 HEPATIC STEATOSIS 61 0.0033
613 MYALGIA 556 0.0033
614 CHOLELITHIASIS 107 0.0033
615 EYE DISORDER 107 0.0033
616 HAEMORRHAGE 340 0.0032
617 SLEEP APNOEA SYNDROME 62 0.0032
618 EYE SWELLING 120 0.0032
619 DYSPEPSIA 317 0.0032
620 RASH PAPULAR 72 0.0032
621 OCULAR DISCOMFORT 36 0.0032
622 PELVIC PAIN 58 0.0032
623 ASTHENIA 1199 0.0032
624 WALKING AID USER 21 0.0032
625 CHEST PAIN 581 0.0031
626 RESTLESS LEGS SYNDROME 57 0.0031
627 SCRATCH 33 0.0031
628 EYE PRURITUS 105 0.0031
629 MUSCLE SPASMS 571 0.0031
630 FOOD ALLERGY 24 0.0031
631 PNEUMONIA 1005 0.0031
632 MACULAR DEGENERATION 37 0.0031
633 PULMONARY MASS 46 0.0031
634 HAEMATOCRIT DECREASED 61 0.0031
635 HYPOAESTHESIA 460 0.0031
636 LIMB DISCOMFORT 95 0.0031
637 NAUSEA 2427 0.0031
638 DIZZINESS 1525 0.0031
639 SCAR 52 0.0030
640 PULMONARY CONGESTION 40 0.0030
641 ANAPHYLACTIC REACTION 167 0.0030
642 MUSCLE INJURY 25 0.0030
643 HYPERTHERMIA 23 0.0030
644 BLOOD MAGNESIUM DECREASED 26 0.0030
645 LACRIMATION INCREASED 91 0.0030
646 CONTUSION 289 0.0030
647 PALPITATIONS 351 0.0030
648 BLOOD TEST ABNORMAL 42 0.0030
649 RESPIRATORY SYNCYTIAL VIRUS INFECTION 26 0.0030
650 HYPERSOMNIA 85 0.0030
651 SWELLING FACE 193 0.0030
652 NEOPLASM 34 0.0030
653 LUNG DISORDER 144 0.0029
654 HAEMOGLOBIN DECREASED 301 0.0029
655 PRODUCT DOSE OMISSION IN ERROR 83 0.0029
656 RASH 1256 0.0029
657 LARGE INTESTINE PERFORATION 20 0.0029
658 VOMITING 1353 0.0029
659 HEPATIC ENZYME INCREASED 196 0.0029
660 DIVERTICULUM 20 0.0028
661 HEPATITIS 72 0.0028
662 NERVOUSNESS 146 0.0028
663 DECREASED APPETITE 647 0.0028
664 MIDDLE INSOMNIA 52 0.0028
665 DRUG INEFFECTIVE 3669 0.0028
666 MENSTRUAL DISORDER 23 0.0028
667 OBESITY 44 0.0028
668 CANDIDA INFECTION 46 0.0027
669 DERMATITIS 57 0.0027
670 LIP SWELLING 90 0.0027
671 HYPOALBUMINAEMIA 21 0.0027
672 HYPERSENSITIVITY 500 0.0027
673 CONTRAINDICATED PRODUCT ADMINISTERED 81 0.0027
674 GAIT DISTURBANCE 512 0.0027
675 TENDON RUPTURE 33 0.0027
676 DEHYDRATION 354 0.0027
677 HYPOAESTHESIA ORAL 40 0.0027
678 LYMPHOMA 41 0.0027
679 OSTEOMYELITIS 48 0.0026
680 DYSURIA 97 0.0026
681 NEURALGIA 64 0.0026
682 INCREASED APPETITE 50 0.0026
683 ANXIETY 744 0.0026
684 DYSPNOEA EXERTIONAL 98 0.0026
685 INTERVERTEBRAL DISC DEGENERATION 24 0.0026
686 GASTRITIS 68 0.0026
687 PARAESTHESIA 406 0.0026
688 PULMONARY THROMBOSIS 28 0.0026
689 PRODUCT CONTAINER ISSUE 22 0.0026
690 DYSPNOEA 1451 0.0026
691 HEAD INJURY 81 0.0026
692 COLON CANCER 38 0.0025
693 HIATUS HERNIA 33 0.0025
694 TACHYCARDIA 224 0.0025
695 SPINAL OPERATION 31 0.0025
696 SYNCOPE 251 0.0025
697 DIARRHOEA 1618 0.0025
698 HEPATIC CIRRHOSIS 47 0.0025
699 GRIP STRENGTH DECREASED 22 0.0025
700 AORTIC ANEURYSM 19 0.0025
701 DRUG INTOLERANCE 241 0.0025
702 STAPHYLOCOCCAL INFECTION 82 0.0025
703 FALL 821 0.0025
704 DYSPHONIA 144 0.0025
705 TINNITUS 113 0.0025
706 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 41 0.0024
707 RED BLOOD CELL COUNT DECREASED 69 0.0024
708 TYPE 2 DIABETES MELLITUS 81 0.0024
709 POST PROCEDURAL HAEMORRHAGE 28 0.0024
710 DYSSTASIA 70 0.0024
711 SPINAL OSTEOARTHRITIS 21 0.0024
712 GASTROOESOPHAGEAL REFLUX DISEASE 192 0.0024
713 OEDEMA PERIPHERAL 290 0.0024
714 BURNING SENSATION 164 0.0023
715 HIP FRACTURE 75 0.0023
716 LETHARGY 134 0.0023
717 SLEEP DISORDER 164 0.0023
718 CAESAREAN SECTION 27 0.0023
719 QUALITY OF LIFE DECREASED 31 0.0023
720 BEDRIDDEN 30 0.0023
721 INCREASED TENDENCY TO BRUISE 21 0.0023
722 PRODUCT ADMINISTRATION ERROR 46 0.0023
723 SINUS DISORDER 45 0.0023
724 CHOLECYSTITIS 27 0.0023
725 BLOOD POTASSIUM DECREASED 68 0.0023
726 OEDEMA 122 0.0022
727 HAEMATEMESIS 57 0.0022
728 HYPOTENSION 451 0.0022
729 EYE PAIN 126 0.0022
730 DERMATITIS ALLERGIC 28 0.0022
731 INABILITY TO AFFORD MEDICATION 22 0.0022
732 RETCHING 47 0.0022
733 PANCREATITIS 116 0.0022
734 ORAL PAIN 49 0.0022
735 CYTOMEGALOVIRUS INFECTION 36 0.0022
736 UPPER RESPIRATORY TRACT INFECTION 100 0.0022
737 MUSCULOSKELETAL PAIN 112 0.0021
738 VITREOUS FLOATERS 21 0.0021
739 EXPIRED PRODUCT ADMINISTERED 71 0.0021
740 HAND DEFORMITY 28 0.0021
741 GLAUCOMA 41 0.0021
742 PHOTOPHOBIA 40 0.0021
743 DEEP VEIN THROMBOSIS 138 0.0021
744 ALOPECIA 417 0.0021
745 LIVER DISORDER 94 0.0021
746 CRYING 77 0.0021
747 RESPIRATORY DISORDER 63 0.0021
748 GASTRIC ULCER 40 0.0021
749 BRADYCARDIA 111 0.0021
750 THROMBOSIS 168 0.0021
751 PULMONARY EMBOLISM 197 0.0021
752 DEVICE MALFUNCTION 145 0.0021
753 THERAPEUTIC RESPONSE DECREASED 125 0.0021
754 VASCULITIS 24 0.0021
755 ANGINA PECTORIS 59 0.0021
756 FEELING ABNORMAL 489 0.0020
757 LOSS OF CONSCIOUSNESS 261 0.0020
758 BLISTER 114 0.0020
759 PNEUMOTHORAX 32 0.0020
760 BLOOD PRESSURE ABNORMAL 40 0.0020
761 SOMNOLENCE 404 0.0020
762 PEMPHIGUS 25 0.0020
763 HYPOKINESIA 29 0.0020
764 NIGHTMARE 69 0.0020
765 INSOMNIA 527 0.0020
766 SKIN ULCER 51 0.0020
767 CYANOSIS 31 0.0020
768 DEMENTIA 55 0.0020
769 LIVER FUNCTION TEST INCREASED 42 0.0020
770 SKIN FISSURES 38 0.0019
771 WHEEZING 115 0.0019
772 GENERALISED OEDEMA 24 0.0019
773 HUNGER 27 0.0019
774 PHOTOSENSITIVITY REACTION 32 0.0019
775 COELIAC DISEASE 19 0.0019
776 EPISTAXIS 144 0.0019
777 ANAEMIA 366 0.0019
778 STOMATITIS 116 0.0019
779 HAEMOPTYSIS 53 0.0019
780 FACE OEDEMA 32 0.0019
781 PANIC ATTACK 69 0.0019
782 THYROID DISORDER 29 0.0019
783 TREMOR 311 0.0019
784 POLLAKIURIA 78 0.0019
785 THERAPY PARTIAL RESPONDER 29 0.0019
786 BIPOLAR DISORDER 20 0.0018
787 DYSPHAGIA 174 0.0018
788 GINGIVAL BLEEDING 25 0.0018
789 PETECHIAE 19 0.0018
790 SURGERY 106 0.0018
791 PRESCRIBED UNDERDOSE 36 0.0018
792 EYE HAEMORRHAGE 24 0.0018
793 HYPERTENSIVE CRISIS 20 0.0018
794 DRY EYE 88 0.0018
795 DEPRESSED MOOD 93 0.0018
796 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 125 0.0018
797 LYMPHOCYTE COUNT DECREASED 31 0.0018
798 MENSTRUATION DELAYED 19 0.0018
799 LUNG NEOPLASM MALIGNANT 72 0.0017
800 FRACTURE 33 0.0017
801 GLOSSODYNIA 39 0.0017
802 BONE PAIN 102 0.0017
803 GENERAL PHYSICAL HEALTH DETERIORATION 200 0.0017
804 NEOPLASM MALIGNANT 115 0.0017
805 DRUG-INDUCED LIVER INJURY 54 0.0017
806 RENAL DISORDER 79 0.0017
807 ACCIDENTAL OVERDOSE 62 0.0017
808 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 92 0.0017
809 PULMONARY FIBROSIS 32 0.0017
810 INJECTION SITE EXTRAVASATION 20 0.0016
811 DIABETES MELLITUS 123 0.0016
812 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 84 0.0016
813 LUNG INFECTION 25 0.0016
814 BLOOD POTASSIUM INCREASED 26 0.0016
815 BACTERAEMIA 19 0.0016
816 LIVER INJURY 39 0.0016
817 DRY SKIN 211 0.0016
818 TRANSIENT ISCHAEMIC ATTACK 53 0.0016
819 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 46 0.0016
820 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 53 0.0016
821 SPINAL FRACTURE 31 0.0015
822 GLOMERULAR FILTRATION RATE DECREASED 19 0.0015
823 HAEMATOMA 40 0.0015
824 BACK DISORDER 25 0.0015
825 ADVERSE DRUG REACTION 138 0.0015
826 SEPSIS 171 0.0015
827 MUSCULAR WEAKNESS 173 0.0015
828 SHOCK 35 0.0015
829 ARRHYTHMIA 72 0.0015
830 ERUCTATION 29 0.0015
831 DEAFNESS 39 0.0015
832 CHOKING 29 0.0015
833 AGEUSIA 37 0.0015
834 PRURITUS GENERALISED 32 0.0015
835 SKIN DISCOLOURATION 68 0.0015
836 BRONCHOSPASM 21 0.0015
837 TACHYPNOEA 20 0.0015
838 VISION BLURRED 200 0.0015
839 URINARY INCONTINENCE 43 0.0014
840 ANOSMIA 21 0.0014
841 MEDICATION ERROR 80 0.0014
842 BLOOD SODIUM DECREASED 27 0.0014
843 BONE DISORDER 26 0.0014
844 CARDIAC DISORDER 133 0.0014
845 CHROMATURIA 32 0.0014
846 ACCIDENTAL EXPOSURE TO PRODUCT 146 0.0014
847 CONFUSIONAL STATE 227 0.0014
848 DYSGEUSIA 104 0.0014
849 ILL-DEFINED DISORDER 85 0.0014
850 PARALYSIS 20 0.0014
851 ANAPHYLACTIC SHOCK 36 0.0014
852 DIPLOPIA 36 0.0014
853 ALANINE AMINOTRANSFERASE INCREASED 85 0.0014
854 PRODUCT PREPARATION ERROR 28 0.0014
855 INJECTION SITE MASS 50 0.0014
856 BLINDNESS UNILATERAL 19 0.0013
857 SPEECH DISORDER 70 0.0013
858 DRUG DOSE OMISSION BY DEVICE 104 0.0013
859 RESTLESSNESS 48 0.0013
860 BLOOD CHOLESTEROL INCREASED 61 0.0013
861 DRY MOUTH 106 0.0013
862 EYE IRRITATION 75 0.0013
863 PAIN OF SKIN 35 0.0013
864 VISUAL IMPAIRMENT 161 0.0013
865 DEPRESSION 294 0.0013
866 ASTHMA 146 0.0013
867 PRODUCT DISPENSING ERROR 28 0.0013
868 PULMONARY OEDEMA 57 0.0013
869 EMOTIONAL DISORDER 39 0.0013
870 SKIN EXFOLIATION 106 0.0013
871 SKIN IRRITATION 57 0.0012
872 BALANCE DISORDER 107 0.0012
873 BLINDNESS 50 0.0012
874 TREATMENT NONCOMPLIANCE 67 0.0012
875 INCORRECT DOSE ADMINISTERED BY DEVICE 32 0.0012
876 OSTEOPOROSIS 50 0.0012
877 HYPOACUSIS 52 0.0012
878 THERAPEUTIC RESPONSE UNEXPECTED 54 0.0012
879 HAEMATURIA 41 0.0012
880 MUSCLE TIGHTNESS 19 0.0012
881 FEAR 31 0.0012
882 CEREBROVASCULAR ACCIDENT 195 0.0011
883 THERAPY CESSATION 58 0.0011
884 BLOOD ALKALINE PHOSPHATASE INCREASED 28 0.0011
885 PANCREATITIS ACUTE 25 0.0011
886 ATRIAL FIBRILLATION 108 0.0011
887 VAGINAL HAEMORRHAGE 48 0.0011
888 MUSCULOSKELETAL DISORDER 21 0.0011
889 PREGNANCY 22 0.0011
890 MUSCLE TWITCHING 25 0.0011
891 AMNESIA 70 0.0011
892 FEMUR FRACTURE 33 0.0011
893 PREMATURE BABY 32 0.0011
894 PRODUCT USE IN UNAPPROVED INDICATION 259 0.0010
895 MENTAL IMPAIRMENT 25 0.0010
896 PRODUCT SUBSTITUTION ISSUE 59 0.0010
897 ASCITES 30 0.0010
898 RESPIRATORY DISTRESS 28 0.0010
899 DISABILITY 20 0.0010
900 GAMMA-GLUTAMYLTRANSFERASE INCREASED 22 0.0010
901 SEIZURE 114 0.0010
902 HYPOPHAGIA 25 0.0010
903 FLUID RETENTION 49 0.0010
904 BLOOD BILIRUBIN INCREASED 26 0.0010
905 GASTRIC DISORDER 33 0.0010
906 MELAENA 21 0.0010
907 LABORATORY TEST ABNORMAL 28 0.0009
908 MEMORY IMPAIRMENT 129 0.0009
909 HOSPITALISATION 143 0.0009
910 NEEDLE ISSUE 27 0.0009
911 DISORIENTATION 34 0.0009
912 PRODUCT DOSE OMISSION 56 0.0009
913 DRUG RESISTANCE 22 0.0009
914 INJECTION SITE BRUISING 68 0.0009
915 PLEURAL EFFUSION 51 0.0008
916 DISTURBANCE IN ATTENTION 45 0.0008
917 JAUNDICE 22 0.0008
918 RENAL IMPAIRMENT 67 0.0008
919 APHASIA 24 0.0008
920 CARDIOVASCULAR DISORDER 20 0.0008
921 INJECTION SITE PAIN 241 0.0008
922 URINARY RETENTION 26 0.0008
923 PSYCHOTIC DISORDER 23 0.0008
924 PRODUCT STORAGE ERROR 68 0.0008
925 MOOD ALTERED 21 0.0008
926 LIVER FUNCTION TEST ABNORMAL 22 0.0008
927 INJURY 53 0.0008
928 HYPOTHYROIDISM 24 0.0008
929 MENSTRUATION IRREGULAR 20 0.0007
930 INJECTION SITE ERYTHEMA 92 0.0007
931 EXPOSURE DURING PREGNANCY 46 0.0007
932 PNEUMONITIS 20 0.0007
933 MYOCARDIAL INFARCTION 126 0.0007
934 EPILEPSY 22 0.0007
935 NERVOUS SYSTEM DISORDER 22 0.0007
936 AGITATION 51 0.0007
937 GASTROINTESTINAL HAEMORRHAGE 58 0.0007
938 HYPOKALAEMIA 32 0.0007
939 BREAST CANCER 64 0.0007
940 INCORRECT DRUG ADMINISTRATION DURATION 19 0.0007
941 BLOOD CREATININE INCREASED 44 0.0007
942 COGNITIVE DISORDER 31 0.0007
943 DELIRIUM 23 0.0007
944 NEUTROPHIL COUNT DECREASED 27 0.0007
945 CORONARY ARTERY DISEASE 20 0.0007
946 INJECTION SITE SWELLING 50 0.0007
947 INJECTION SITE RASH 20 0.0007
948 SUICIDAL IDEATION 59 0.0006
949 INJECTION SITE PRURITUS 43 0.0006
950 ASPARTATE AMINOTRANSFERASE INCREASED 34 0.0006
951 CARDIAC FAILURE 50 0.0006
952 INTERSTITIAL LUNG DISEASE 30 0.0006
953 IRRITABILITY 37 0.0006
954 PROSTATE CANCER 49 0.0006
955 BLOOD GLUCOSE DECREASED 29 0.0006
956 AGGRESSION 30 0.0006
957 DRUG EFFECT DECREASED 32 0.0006
958 DEATH 505 0.0006
959 MULTIPLE SCLEROSIS 28 0.0006
960 WHITE BLOOD CELL COUNT DECREASED 63 0.0006
961 HYPOGLYCAEMIA 28 0.0006
962 SKIN BURNING SENSATION 41 0.0006
963 HYPOXIA 20 0.0006
964 ANGIOEDEMA 25 0.0006
965 SEPTIC SHOCK 24 0.0006
966 BLADDER CANCER 32 0.0005
967 INJECTION SITE HAEMORRHAGE 43 0.0005
968 RENAL FAILURE 71 0.0005
969 NEUROPATHY PERIPHERAL 49 0.0005
970 ADVERSE EVENT 47 0.0005
971 DYSARTHRIA 19 0.0005
972 EXTRA DOSE ADMINISTERED 20 0.0005
973 INTENTIONAL PRODUCT MISUSE 43 0.0005
974 CARDIAC FAILURE CONGESTIVE 37 0.0005
975 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 20 0.0004
976 PLATELET COUNT DECREASED 44 0.0004
977 BLOOD GLUCOSE INCREASED 72 0.0004
978 EMOTIONAL DISTRESS 45 0.0004
979 DISEASE PROGRESSION 42 0.0004
980 CARDIAC ARREST 29 0.0004
981 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 67 0.0003
982 INJECTION SITE REACTION 22 0.0003
983 FOETAL EXPOSURE DURING PREGNANCY 24 0.0003
984 DRUG INTERACTION 42 0.0003
985 NO ADVERSE EVENT 46 0.0003
986 ACUTE KIDNEY INJURY 36 0.0002
987 DRUG DOSE OMISSION 34 0.0002
988 DRUG DEPENDENCE 24 0.0001
989 NEUTROPENIA 20 0.0001